JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by LUCIA, S. P.
Right arrow Articles by BROWN, J. W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by LUCIA, S. P.
Right arrow Articles by BROWN, J. W.
Journal of Pharmacology And Experimental Therapeutics, Vol. 52, Issue 4, 418-429, 1934
Copyright © 1934 by American Society for Pharmacology and Experimental Therapeutics


THE EFFECTS OF POTASSIUM ANTIMONYL TARTRATE ON THE BLOOD AND HEMATOPOIETIC ORGANS

S. P. LUCIA 1 and J. W. BROWN 1

1 From the Departments of Medicine and Pathology, University of California Medical School, San Francisco, California

When the normal rabbit is inoculated intravenously with the maximal tolerated dose of potassium antimonyl tartrate there results an immediate leucopenia without secondary leucocytosis, the red blood corpuscle count remains unchanged, and an increased number of normoblasts appear in the peripheral blood. Potassium antimonyl tartrate depresses both the polymorphonuclear neutrophile and the lymphocyte counts, the former more rapidly and more profoundly than the latter. When injections of potassium antimonyl tartrate are given over a long period of time the same quantitative alterations occur in the peripheral blood after each injection, as are noted after the first injection. Potassium antimonyl tartrate does not destroy the leucocytes of the rabbits in vitro. The inoculated antimony disappears from the circulating blood of the rabbit within one-half hour after inoculation. The maximal tolerated dose of potassium antimonyl tartrate (6 mgm. per kilogram) in the rabbit produces a varying grade of periportal fibrosis in the liver, increased phagocytosis in the spleen, and a mild grade of erythropoietic hyperplasia in the bone marrow. The destruction of leucocytes probably takes place in the spleen.

Submitted on August 23, 1934







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1934 by the American Society for Pharmacology and Experimental Therapeutics.